The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...

Asthma is a common prevalent chronic respiratory illness that affects millions of people all over the world in every age group. Asthma is defined as inflamed and constricted airways, causing repeated ...

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A mother encourages her daughter to fully open her mouth to swallow a live fish holding “the medicine” she believes will help cure her child’s asthma, as scores clamor about, gulping down their own ...

The month of May is known as, National Asthma and Allergy Awareness Month, making it the ultimate time to prioritize ...

Asthma affects more women than men in adulthood, yet it rarely features in the broader women’s health conversation.